Promius Pharma and Valeant form collaboration to market Cloderm® Cream in the United States.
Promius Pharma, LLC has announced the launch of Promiseb™ Topical Cream, a non-steroidal, prescription only, cream for the treatment of seborrheic dermatitis, that has demonstrated both anti-inflammatory and antifungal properties.
Promius Pharma, LLC, has launched Scytera™(coal tar) Foam 2% for the treatment of chronic psoriasis, a skin disease that affects approximately 7.5 million Americans according to The National Psoriasis Foundation.
September 18, 2008
Dr. Reddy's formally announces its US Specialty Business, Promius Pharma, LLC
September 03, 2008
Antares Pharma enters into a feasibility development agreement with Dr. Reddy's Laboratories for an enhanced dermatology product utilizing the ATD gel platform.
September 27, 2007
Sinclair Pharma plc announces Dr Reddy's Laboratories as Sebclair marketing partner in US.
January 24, 2007
Foamix signs R&D collaboration and license agreement with Dr. Reddy's for the development and commercialization of psoriasis foam.